Evaluation of glucosamine coated mesoporous silica nanoparticles for antioxidant activity cytocompatibility and blood brain barrier permeability in amyotrophic lateral sclerosis
Year: 2026
Type: article
Abstract: Amyotrophic lateral sclerosis (ALS) remains a fatal neurodegenerative disease with limited disease-modifying options, and effective delivery of therapeutics to the central nervous system is hindered by the blood-brain barrier (BBB). Here, we report mesoporous silica nanoparticles (MSNs) designed as a combination-delivery platform integrating riluzole, 5-methoxytryptamine (5MT) as an antioxidant-related component, and glucosamine as a biomolecular surface coating. The resulting multifunctional nanosystems were prepared and characterized by complementary physicochemical techniques, supporting successful incorporation of the selected components within the MSN-based carrier. To obtain a first-pass indication of brain-oriented delivery feasibility, permeability was assessed using a PAMPA-BBB assay that mimics key features of the brain lipid environment. This screening assay showed formulation-dependent apparent silica carryover across the artificial lipid membrane and provides a basis for subsequent evaluation in cell-based BBB models, supporting their further evaluation as ALS-oriented nanodelivery candidates. Overall, these results establish a rational proof-of concept of MSN platform for combination delivery and provide a permeability-screening basis for subsequent studies in more advanced BBB and neurobiological models, supporting their further evaluation as multifunctional delivery platforms for neurodegenerative diseases, such as ALS.
Source: Discover Nano
Institution: Universidad Rey Juan Carlos
Language: English
Subfield: Biomaterials
Field: Materials Science
Domain: Physical Sciences
Open Access status: gold
Estimated APC paid: $2,090
OpenAlex ID: W7236762273
